The findings suggest that therapeutics targeting the path between two critical brain regions, the amygdala and the nucleus accumbens, represent potential treatments for addiction and other neuropsychiatric diseases.
The findings suggest that therapeutics targeting the path between two critical brain regions, the amygdala and the nucleus accumbens, represent potential treatments for addiction and other neuropsychiatric diseases.